Dr Martens /£DOCS
07:00
09:10
11:15
13:25
15:30
1D1W1MYTD1Y5YMAX
About Dr Martens
Dr. Martens, also known as Docs or DMs, is a United Kingdom-based company renowned for its iconic range of footwear, alongside a variety of clothing and accessories. The company, headquartered in Wollaston, Northamptonshire, operates primarily in the footwear manufacturing sector. Established in 1947, Dr. Martens has grown to become a symbol of self-expression and counterculture, distributing its products worldwide under the Dr. Martens brand.
Ticker
£DOCS
Sector
Primary listing
LSE
Industry
Textiles, Apparel & Luxury Goods
Headquarters
Employees
2,348
ISIN
GB00BL6NGV24
Website
Dr Martens Metrics
BasicAdvanced
£722M
161.46
£0.00
0.15
£0.02
2.44%
Price and volume
Market cap
£722M
Beta
0.15
52-week high
£0.83
52-week low
£0.43
Average daily volume
2M
Dividend rate
£0.02
Financial strength
Current ratio
2.591
Quick ratio
1.368
Long term debt to equity
97.107
Total debt to equity
110.289
Dividend payout ratio (TTM)
211.11%
Interest coverage (TTM)
2.01%
Profitability
EBITDA (TTM)
75.7
Gross margin (TTM)
64.97%
Net profit margin (TTM)
0.57%
Operating margin (TTM)
7.71%
Effective tax rate (TTM)
48.86%
Revenue per employee (TTM)
£340,000
Management effectiveness
Return on assets (TTM)
4.12%
Return on equity (TTM)
1.23%
Valuation
Price to earnings (TTM)
161.463
Price to revenue (TTM)
0.922
Price to book
1.97
Price to tangible book (TTM)
7.81
Price to free cash flow (TTM)
4.091
Free cash flow yield (TTM)
24.44%
Free cash flow per share (TTM)
18.46%
Dividend yield (TTM)
2.44%
Growth
Revenue change (TTM)
-10.20%
Earnings per share change (TTM)
-93.32%
3-year revenue growth (CAGR)
-4.64%
10-year revenue growth (CAGR)
12.84%
3-year earnings per share growth (CAGR)
-70.44%
10-year earnings per share growth (CAGR)
36.65%
3-year dividend per share growth (CAGR)
-22.60%
What the Analysts think about Dr Martens
Analyst ratings (Buy, Hold, Sell) for Dr Martens stock.
Bulls say / Bears say
Dr. Martens plans to reduce discounting in key markets, including the U.S., aiming for a return to profit growth in the current financial year. (reuters.com)
The company reported an adjusted pre-tax profit of £34.1 million for the year ending March 31, 2025, surpassing analyst expectations of £30.6 million. (reuters.com)
Berenberg analysts initiated coverage with a 'Buy' rating and a price target of £1.02, highlighting significant potential for global expansion due to strong brand recognition and minimal current market share. (investing.com)
Dr. Martens issued its fourth profit warning in 12 months, citing lackluster demand from U.S. wholesalers and a slower start to the autumn-winter season. (reuters.com)
The company anticipates a single-digit percentage decline in revenue for the year ending March 2024, with full-year core profit expected to be moderately below the bottom end of market expectations. (reuters.com)
Dr. Martens' shares plunged 30% to a record low after flagging a challenging 2025 outlook due to weaker revenues, particularly in the U.S. market. (nbcboston.com)
Data summarised monthly by Lightyear AI. Last updated on 6 Jun 2025.
Dr Martens Financial Performance
Revenues and expenses
Dr Martens Earnings Performance
Company profitability
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.
Capital at risk
Upcoming events
Aug28
Dr Martens
Dividend·Ex-dividend
Oct8
Dr Martens
Dividend·Payment
£0.017Per share
FAQs
What’s the current market cap for Dr Martens stock?
Dr Martens (DOCS) has a market cap of £722M as of June 28, 2025.
What is the P/E ratio for Dr Martens stock?
The price to earnings (P/E) ratio for Dr Martens (DOCS) stock is 161.46 as of June 28, 2025.
Does Dr Martens stock pay dividends?
Yes, the Dr Martens (DOCS) stock pays dividends to shareholders. As of June 28, 2025, the dividend rate is £0.0184 and the yield is 2.44%. Dr Martens has a payout ratio of 211.11% on a trailing twelve-month basis.
When is the next Dr Martens dividend payment date?
The next Dr Martens (DOCS) dividend payment is scheduled for October 08, 2025.
What is the beta indicator for Dr Martens ?
Dr Martens (DOCS) has a beta rating of 0.15. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.